CLINICAL_TRIALS
trial_result
· 2014-11-04
Clinical Trial Update: Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack [Phase 2]
Summary
A Phase 2 study evaluating BB3 for treatment of myocardial infarction was terminated, and results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Angion Biomedica Corp | Conditions: Myocardial Infarction | Phase 2 | Status: TERMINATED | Results posted: 2014-11-04